-
1
-
-
0031984207
-
Cancer statistics by race and ethnicity
-
Parker SL, Davis KJ, Wingo PA, Ries LA and Heath CW Jr: Cancer statistics by race and ethnicity. CA Cancer J Clin 48: 31-48, 1998. (Pubitemid 28045532)
-
(1998)
Ca-A Cancer Journal for Clinicians
, vol.48
, Issue.1
, pp. 31-48
-
-
Parker, S.L.1
Davis, K.J.2
Wingo, P.A.3
Ries, L.A.G.4
Heath Jr., C.W.5
-
2
-
-
0037260139
-
Cancer statistics, 2003
-
Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 53: 5-26, 2003. (Pubitemid 36163619)
-
(2003)
Ca-A Cancer Journal for Clinicians
, vol.53
, Issue.1
, pp. 5-26
-
-
Jemal, A.1
Murray, T.2
Samuels, A.3
Ghafoor, A.4
Ward, E.5
Thun, M.J.6
-
3
-
-
0038481707
-
Current strategies in the management of hormone refractory prostate cancer
-
DOI 10.1016/S0305-7372(02)00090-7
-
Martel CL, Gumerlock PH, Meyers FJ and Lara PN: Current strategies in the management of hormone refractory prostate cancer. Cancer Treat Rev 29: 171-187, 2003. (Pubitemid 36763942)
-
(2003)
Cancer Treatment Reviews
, vol.29
, Issue.3
, pp. 171-187
-
-
Martel, C.L.1
Gumerlock, P.H.2
Meyers, F.J.3
Lara Jr., P.N.4
-
4
-
-
0034296761
-
Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis
-
Hyer ML, Voelkel-Johnson C, Rubinchik S, Dong J and Norris JS: Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis. Mol Ther 2: 348-358, 2000.
-
(2000)
Mol Ther
, vol.2
, pp. 348-358
-
-
Hyer, M.L.1
Voelkel-Johnson, C.2
Rubinchik, S.3
Dong, J.4
Norris, J.S.5
-
5
-
-
0033942505
-
Apoptosis in prostate carcinogenesis: A growth regulator and a therapeutic target
-
Bruckheimer EM and Kyprianou N: Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res 301: 153-162, 2000. (Pubitemid 30459862)
-
(2000)
Cell and Tissue Research
, vol.301
, Issue.1
, pp. 153-162
-
-
Bruckheimer, E.M.1
Kyprianou, N.2
-
6
-
-
16444386240
-
Primary cell cultures as models of prostate cancer development
-
Peehl DM: Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 12: 19-47, 2005.
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 19-47
-
-
Peehl, D.M.1
-
8
-
-
0031577480
-
Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21(WAF/CIP1) in p53-independent manner
-
DOI 10.1006/bbrc.1997.7158
-
Xiao H, Hasegawa T, Miyaishi O, Ohkusu K and Isobe K: Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner. Biochem Biophys Res Commun 237: 457-460, 1997. (Pubitemid 27406052)
-
(1997)
Biochemical and Biophysical Research Communications
, vol.237
, Issue.2
, pp. 457-460
-
-
Xiao, H.1
Hasegawa, T.2
Miyaishi, O.3
Ohkusu, K.4
Isobe, K.-I.5
-
9
-
-
0038555374
-
Short-chain fatty acid inhibitors of histone deacetylases: Promising anticancer therapeutics?
-
DOI 10.2174/1568009033481994
-
Chen JS, Faller DV and Spanjaard RA: Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets 3: 219-236, 2003. (Pubitemid 36565763)
-
(2003)
Current Cancer Drug Targets
, vol.3
, Issue.3
, pp. 219-236
-
-
Chen, J.S.1
Faller, D.V.2
Spanjaard, R.A.3
-
10
-
-
0029962932
-
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate
-
Carducci MA, Nelson JB, Chan-Tack KM, et al.: Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate. Clin Cancer Res 2: 379-387, 1996. (Pubitemid 26075641)
-
(1996)
Clinical Cancer Research
, vol.2
, Issue.2
, pp. 379-387
-
-
Carducci, M.A.1
Nelson, J.B.2
Chan-Tack, K.M.3
Ayyagari, S.R.4
Sweatt, W.H.5
Campbell, P.A.6
Nelson, W.G.7
Simons, J.W.8
-
11
-
-
0032104814
-
Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model
-
DOI 10.1002/(SICI)1097-4644(19980601)69:3<271::AID-JCB5>3.0.CO;2-O
-
Gleave ME, Sato N, Sadar M, Yago V, Bruchovsky N and Sullivan L: Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model. J Cell Biochem 69: 271-281, 1998. (Pubitemid 28227704)
-
(1998)
Journal of Cellular Biochemistry
, vol.69
, Issue.3
, pp. 271-281
-
-
Gleave, M.E.1
Sato, N.2
Sadar, M.3
Yago, V.4
Bruchovsky, N.5
Sullivan, L.6
-
12
-
-
0033819161
-
Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines
-
Maier S, Reich E, Martin R, et al.: Tributyrin induces differentiation, growth arrest and apoptosis in androgen-sensitive and androgen-resistant human prostate cancer cell lines. Int J Cancer 88: 245-251, 2000.
-
(2000)
Int J Cancer
, vol.88
, pp. 245-251
-
-
Maier, S.1
Reich, E.2
Martin, R.3
-
13
-
-
0035146929
-
Life-or-death decisions by the Bcl-2 protein family
-
DOI 10.1016/S0968-0004(00)01740-0, PII S0968000400017400
-
Adams JM and Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66, 2001. (Pubitemid 32124712)
-
(2001)
Trends in Biochemical Sciences
, vol.26
, Issue.1
, pp. 61-66
-
-
Adams, J.M.1
Cory, S.2
-
14
-
-
0034899716
-
Shared pathways: Death receptors and cytotoxic drugs in cancer therapy
-
Petak I and Houghton JA: Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 7: 95-106, 2001. (Pubitemid 32729759)
-
(2001)
Pathology Oncology Research
, vol.7
, Issue.2
, pp. 95-106
-
-
Petak, I.1
Houghton, J.A.2
-
15
-
-
0018847558
-
The LNCaP cell line-a new model for studies on human prostatic carcinoma
-
Horoszewicz JS, Leong SS, Chu TM, et al.: The LNCaP cell line-a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115-132, 1980.
-
(1980)
Prog Clin Biol Res
, vol.37
, pp. 115-132
-
-
Horoszewicz, J.S.1
Leong, S.S.2
Chu, T.M.3
-
16
-
-
0020638814
-
LNCaP model of human prostatic carcinoma
-
Horoszewicz JS, Leong SS, Kawinski E, et al.: LNCaP model of human prostatic carcinoma. Cancer Res 43: 1809-1818, 1983. (Pubitemid 13122588)
-
(1983)
Cancer Research
, vol.43
, Issue.4
, pp. 1809-1818
-
-
Horoszewicz, J.S.1
Leong, S.S.2
Kawinski, E.3
-
17
-
-
0018815211
-
Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice
-
Mickey DD, Stone KR, Wunderli H, Mickey GH and Paulson DF: Characterization of a human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice. Prog Clin Biol Res 37: 67-84, 1980.
-
(1980)
Prog Clin Biol Res
, vol.37
, pp. 67-84
-
-
Mickey, D.D.1
Stone, K.R.2
Wunderli, H.3
Mickey, G.H.4
Paulson, D.F.5
-
18
-
-
0018779369
-
Establishment and characterization of a human prostatic carcinoma cell line (PC-3)
-
Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF and Jones LW: Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16-23, 1979. (Pubitemid 9239413)
-
(1979)
Investigative Urology
, vol.17
, Issue.1
, pp. 16-23
-
-
Kaighn, M.E.1
Shankar, N.K.2
Ohnuki, Y.3
-
19
-
-
0033105947
-
Analysis of apoptosis by laser scanning cytometry
-
DOI 10.1002/(SICI)1097-0320(19990301)35:3<181::AID-CYTO1>3.0.CO;2-5
-
Bedner E, Li X, Gorczyca W, Melamed MR and Darzynkiewicz Z: Analysis of apoptosis by laser scanning cytometry. Cytometry 35: 181-195, 1999. (Pubitemid 29104396)
-
(1999)
Cytometry
, vol.35
, Issue.3
, pp. 181-195
-
-
Bedner, E.1
Li, X.2
Gorczyca, W.3
Melamed, M.R.4
Darzynkiewicz, Z.5
-
20
-
-
6444230927
-
Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: A p53-independent mitochondrial-mediated apoptotic mechanism
-
DOI 10.1093/carcin/bgh201
-
Shibata MA, Ito Y, Morimoto J and Otsuki Y: Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism. Carcinogenesis 25: 1887-1898, 2004. (Pubitemid 39405908)
-
(2004)
Carcinogenesis
, vol.25
, Issue.10
, pp. 1887-1898
-
-
Shibata, M.-A.1
Ito, Y.2
Morimoto, J.3
Otsuki, Y.4
-
21
-
-
0038147200
-
Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines
-
DOI 10.1167/iovs.02-1052
-
Klisovic DD, Katz SE, Effron D, et al.: Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines. Invest Ophthalmol Vis Sci 44: 2390-2398, 2003. (Pubitemid 36618393)
-
(2003)
Investigative Ophthalmology and Visual Science
, vol.44
, Issue.6
, pp. 2390-2398
-
-
Klisovic, D.D.1
Katz, S.E.2
Effron, D.3
Klisovic, M.I.4
Wickham, J.5
Parthun, M.R.6
Guimond, M.7
Marcucci, G.8
-
22
-
-
0035525781
-
Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: A case report
-
Piekarz RL, Robey R, Sandor V, et al.: Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report. Blood 98: 2865-2868, 2001.
-
(2001)
Blood
, vol.98
, pp. 2865-2868
-
-
Piekarz, R.L.1
Robey, R.2
Sandor, V.3
-
23
-
-
0036301281
-
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
-
Sandor V, Bakke S, Robey RW, et al.: Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms. Clin Cancer Res 8: 718-728, 2002. (Pubitemid 34742100)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.3
, pp. 718-728
-
-
Sandor, V.1
Bakke, S.2
Robey, R.W.3
Kang, M.H.4
Blagosklonny, M.V.5
Bender, J.6
Brooks, R.7
Piekarz, R.L.8
Tucker, E.9
Figg, W.D.10
Chan, K.K.11
Goldspiel, B.12
Fojo, A.T.13
Balcerzak, S.P.14
Bates, S.E.15
-
24
-
-
0037050728
-
Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells
-
DOI 10.1002/ijc.10082
-
Suenaga M, Soda H, Oka M, et al.: Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells. Int J Cancer 97: 621-625, 2002. (Pubitemid 34087800)
-
(2002)
International Journal of Cancer
, vol.97
, Issue.5
, pp. 621-625
-
-
Suenaga, M.1
Soda, H.2
Oka, M.3
Yamaguchi, A.4
Nakatomi, K.5
Shiozawa, K.6
Kawabata, S.7
Kasai, T.8
Yamada, Y.9
Kamihira, S.10
Tei, C.11
Kohno, S.12
-
25
-
-
0034665124
-
Suberoylanilide hydro-xamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
-
Butler LM, Agus DB, Scher HI, et al.: Suberoylanilide hydro-xamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60: 5165-5170, 2000.
-
(2000)
Cancer Res
, vol.60
, pp. 5165-5170
-
-
Butler, L.M.1
Agus, D.B.2
Scher, H.I.3
-
26
-
-
0033071024
-
Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1
-
Ellerhorst J, Nguyen T, Cooper DN, Estrov Y, Lotan D and Lotan R: Induction of differentiation and apoptosis in the prostate cancer cell line LNCaP by sodium butyrate and galectin-1. Int J Oncol 14: 225-232, 1999.
-
(1999)
Int J Oncol
, vol.14
, pp. 225-232
-
-
Ellerhorst, J.1
Nguyen, T.2
Cooper, D.N.3
Estrov, Y.4
Lotan, D.5
Lotan, R.6
-
27
-
-
0038060250
-
Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo
-
DOI 10.1016/S0304-3835(03)00184-8
-
Sasakawa Y, Naoe Y, Inoue T, et al.: Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivo. Cancer Lett 195: 161-168, 2003. (Pubitemid 36588965)
-
(2003)
Cancer Letters
, vol.195
, Issue.2
, pp. 161-168
-
-
Sasakawa, Y.1
Naoe, Y.2
Inoue, T.3
Sasakawa, T.4
Matsuo, M.5
Manda, T.6
Mutoh, S.7
-
28
-
-
0029119740
-
Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
-
Grana X and Reddy EP: Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 11: 211-219, 1995.
-
(1995)
Oncogene
, vol.11
, pp. 211-219
-
-
Grana, X.1
Reddy, E.P.2
-
29
-
-
0028931265
-
Principles of CDK regulation
-
Morgan DO: Principles of CDK regulation. Nature 374: 131-134, 1995.
-
(1995)
Nature
, vol.374
, pp. 131-134
-
-
Morgan, D.O.1
-
30
-
-
0027938209
-
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
-
DOI 10.1016/0092-8674(94)90543-6
-
Hunter T and Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994. (Pubitemid 24363801)
-
(1994)
Cell
, vol.79
, Issue.4
, pp. 573-582
-
-
Hunter, T.1
Pines, J.2
-
31
-
-
0033564697
-
1-phase progression
-
Sherr CJ and Roberts JM: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512, 1999. (Pubitemid 29297917)
-
(1999)
Genes and Development
, vol.13
, Issue.12
, pp. 1501-1512
-
-
Sherr, C.J.1
Roberts, J.M.2
-
32
-
-
0037075887
-
Cyclin D-dependent kinases, INK4 inhibitors and cancer
-
DOI 10.1016/S0304-419X(02)00037-9, PII S0304419X02000379
-
Ortega S, Malumbres M and Barbacid M: Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-87, 2002. (Pubitemid 34311901)
-
(2002)
Biochimica et Biophysica Acta - Reviews on Cancer
, vol.1602
, Issue.1
, pp. 73-87
-
-
Ortega, S.1
Malumbres, M.2
Barbacid, M.3
-
33
-
-
33750733622
-
Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells
-
Wu ZZ, Chien CM, Yang SH, et al.: Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells. Mol Cell Biochem 292: 99-105, 2006.
-
(2006)
Mol Cell Biochem
, vol.292
, pp. 99-105
-
-
Wu, Z.Z.1
Chien, C.M.2
Yang, S.H.3
-
34
-
-
0029670477
-
Translational control of p27Kip1 accumulation during the cell cycle
-
Hengst L and Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 271: 1861-1864, 1996.
-
(1996)
Science
, vol.271
, pp. 1861-1864
-
-
Hengst, L.1
Reed, S.I.2
-
35
-
-
0034109296
-
The cell cycle inhibitors p21(WAF1) and p27(KIP1) are associated with survival in patients treated by salvage prostatectomy after radiation therapy
-
Cheng L, Lloyd RV, Weaver AL, Pisansky TM, Cheville JC, Ramnani DM, Leibovich BC, Blute ML, Zincke H and Bostwick DG: The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy. Clin Cancer Res 6: 1896-1899, 2000. (Pubitemid 30305087)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.5
, pp. 1896-1899
-
-
Cheng, L.1
Lloyd, R.V.2
Weaver, A.L.3
Pisansky, T.M.4
Cheville, J.C.5
Ramnani, D.M.6
Leibovich, B.C.7
Blute, M.L.8
Zincke, H.9
Bostwich, D.G.10
-
36
-
-
0034011051
-
Multiple functions of p27(Kip1) and its alterations in tumor cells: A review
-
DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S
-
Sgambato A, Cittadini A, Faraglia B and Weinstein IB: Multiple functions of p27(Kip1) and its alterations in tumor cells: a review. J Cell Physiol 183: 18-27, 2000. (Pubitemid 30130221)
-
(2000)
Journal of Cellular Physiology
, vol.183
, Issue.1
, pp. 18-27
-
-
Sgambato, A.1
Cittadini, A.2
Faraglia, B.3
Weinstein, I.B.4
-
37
-
-
0036581949
-
Phytochemicals as cell cycle modulators: A less toxic approach in halting human cancers
-
Singh RP, Dhanalakshmi S and Agarwal R: Phytochemicals as cell cycle modulators: a less toxic approach in halting human cancers. Cell Cycle 1: 156-161, 2002.
-
(2002)
Cell Cycle
, vol.1
, pp. 156-161
-
-
Singh, R.P.1
Dhanalakshmi, S.2
Agarwal, R.3
-
38
-
-
0035049060
-
Apoptosis and its clinical impact
-
Gastman BR: Apoptosis and its clinical impact. Head Neck 23: 409-425, 2001.
-
(2001)
Head Neck
, vol.23
, pp. 409-425
-
-
Gastman, B.R.1
-
39
-
-
0033280669
-
Biochemical pathways of caspase activation during apoptosis
-
DOI 10.1146/annurev.cellbio.15.1.269
-
Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999. (Pubitemid 32250377)
-
(1999)
Annual Review of Cell and Developmental Biology
, vol.15
, pp. 269-290
-
-
Budihardjo, I.1
Oliver, H.2
Lutter, M.3
Luo, X.4
Wang, X.5
-
40
-
-
0037276437
-
The CD95(APO-1/Fas) DISC and beyond
-
DOI 10.1038/sj.cdd.4401186
-
Peter ME and Krammer PH: The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ 10: 26-35, 2003. (Pubitemid 36511830)
-
(2003)
Cell Death and Differentiation
, vol.10
, Issue.1
, pp. 26-35
-
-
Peter, M.E.1
Krammer, P.H.2
-
41
-
-
0028327190
-
Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness
-
Owen-Schaub LB, Radinsky R, Kruzel E, Berry K and Yonehara S: Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 54: 1580-1586, 1994. (Pubitemid 24106426)
-
(1994)
Cancer Research
, vol.54
, Issue.6
, pp. 1580-1586
-
-
Owen-Schaub, L.B.1
Radinsky, R.2
Kruzel, E.3
Berry, K.4
Yonehara, S.5
-
42
-
-
0031834910
-
Fas-mediated apoptosis in seven human prostate cancer cell lines: Correlation with tumor stage
-
DOI 10.1002/(SICI)1097-0045(19980701)36:2<92::AID-PROS4>3.0.CO;2-G
-
Hedlund TE, Duke RC, Schleicher MS and Miller GJ: Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36: 92-101, 1998. (Pubitemid 28311313)
-
(1998)
Prostate
, vol.36
, Issue.2
, pp. 92-101
-
-
Hedlund, T.E.1
Duke, R.C.2
Schleicher, M.S.3
Miller, G.J.4
-
43
-
-
14444279883
-
Fas-mediated apoptosis in human prostatic carcinoma cell lines
-
Rokhlin OW, Bishop GA, Hostager BS, et al.: Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res 57: 1758-1768, 1997. (Pubitemid 27199671)
-
(1997)
Cancer Research
, vol.57
, Issue.9
, pp. 1758-1768
-
-
Rokhlin, O.W.1
Bishop, G.A.2
Hostager, B.S.3
Waldschmidt, T.J.4
Sidorenko, S.P.5
Pavloff, N.6
Kiefer, M.C.7
Umansky, S.R.8
Glover, R.A.9
Cohen, M.B.10
-
44
-
-
0033153086
-
The role of caspases in development, immunity, and apoptotic signal transduction: Lessons from knockout mice
-
DOI 10.1016/S1074-7613(00)80062-X
-
Los M, Wesselborg S and Schulze-Osthoff K: The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10: 629-639, 1999. (Pubitemid 29302916)
-
(1999)
Immunity
, vol.10
, Issue.6
, pp. 629-639
-
-
Los, M.1
Wesselborg, S.2
Schulze-Osthoff, K.3
-
45
-
-
0027331496
-
1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene
-
Xu HM, Tepper CG, Jones JB, Fernandez CE and Studzinski GP: 1,25-Dihydroxyvitamin D3 protects HL60 cells against apoptosis but down-regulates the expression of the bcl-2 gene. Exp Cell Res 209: 367-374, 1993.
-
(1993)
Exp Cell Res
, vol.209
, pp. 367-374
-
-
Xu, H.M.1
Tepper, C.G.2
Jones, J.B.3
Fernandez, C.E.4
Studzinski, G.P.5
-
46
-
-
0029964257
-
Taxol induces bcl-2 phosphorylation and death of prostate cancer cells
-
Haldar S, Chintapalli J and Croce CM: Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res 56: 1253-1255, 1996. (Pubitemid 26080965)
-
(1996)
Cancer Research
, vol.56
, Issue.6
, pp. 1253-1255
-
-
Haldar, S.1
Chintapalli, J.2
Croce, C.M.3
-
47
-
-
0036152740
-
Sodium butyrate induces P53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells
-
Chopin V, Toillon RA, Jouy N and Le Bourhis X: Sodium butyrate induces p53-independent, Fas-mediated apoptosis in MCF-7 human breast cancer cells. Br J Pharmacol 135: 79-86, 2002. (Pubitemid 34102100)
-
(2002)
British Journal of Pharmacology
, vol.135
, Issue.1
, pp. 79-86
-
-
Chopin, V.1
Toillon, R.-A.2
Jouy, N.3
Le, B.X.4
-
48
-
-
0033938117
-
Life and death decisions: Regulation of apoptosis by proteolysis of signaling molecules
-
Utz PJ and Anderson P: Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules. Cell Death Differ 7: 589-602, 2000. (Pubitemid 30456165)
-
(2000)
Cell Death and Differentiation
, vol.7
, Issue.7
, pp. 589-602
-
-
Utz, P.J.1
Anderson, P.2
|